including historical data in the analysis of clinical ... · joost van rosmalen1, david...

25
Modified power priors: theoretical overview and sampling algorithms Including historical data in the analysis of clinical trials using the modified power priors: theoretical overview and sampling algorithms Joost van Rosmalen 1 , David Dejardin 2,3 , and Emmanuel Lesaffre 1,2 1 Department of Biostatistics, Erasmus MC, Rotterdam, the Netherlands 2 I-BioStat, KU Leuven, Leuven, Belgium 3 Biometrics, Roche Pharmaceutical Research and Early Development, Basel, Switzerland Bayes Pharma meeting 2014 Bayes Pharma meeting 2014 1 / 25

Upload: others

Post on 24-Sep-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Including historical data in the analysis of clinical ... · Joost van Rosmalen1, David Dejardin2;3, and Emmanuel Lesa re1;2 1Department of Biostatistics, Erasmus MC, Rotterdam, the

Modified power priors: theoretical overview and sampling algorithms

Including historical data in the analysis of clinical trialsusing the modified power priors:

theoretical overview and sampling algorithms

Joost van Rosmalen1, David Dejardin2,3, and Emmanuel Lesaffre1,2

1Department of Biostatistics, Erasmus MC, Rotterdam, the Netherlands

2I-BioStat, KU Leuven, Leuven, Belgium

3Biometrics, Roche Pharmaceutical Research and Early Development, Basel, Switzerland

Bayes Pharma meeting 2014

Bayes Pharma meeting 2014 1 / 25

Page 2: Including historical data in the analysis of clinical ... · Joost van Rosmalen1, David Dejardin2;3, and Emmanuel Lesa re1;2 1Department of Biostatistics, Erasmus MC, Rotterdam, the

Modified power priors: theoretical overview and sampling algorithms

Contents

Introduction

Theoretical overview

Sampling algorithms

Behaviour of modified power prior

Discussion

Bayes Pharma meeting 2014 2 / 25

Page 3: Including historical data in the analysis of clinical ... · Joost van Rosmalen1, David Dejardin2;3, and Emmanuel Lesa re1;2 1Department of Biostatistics, Erasmus MC, Rotterdam, the

Modified power priors: theoretical overview and sampling algorithms

Introduction

Including historical data in analysis of clinical studies is a tantalizingprospect.

Advantages: improved precision and statistical power, fewer patientsneeded in new study.

Common example: RCTs in which control group receives sametreatment as in previous studies.

Including historical data in analysis is controversial.

Bayes Pharma meeting 2014 3 / 25

Page 4: Including historical data in the analysis of clinical ... · Joost van Rosmalen1, David Dejardin2;3, and Emmanuel Lesa re1;2 1Department of Biostatistics, Erasmus MC, Rotterdam, the

Modified power priors: theoretical overview and sampling algorithms

Introduction

Hypothetical example: probability of success of new surgical technique

Current study: 50 successes out of 100 cases

Previous study: 50 successes out of 100 cases

Binomial model, uniform prior for probability

Bayes Pharma meeting 2014 4 / 25

Page 5: Including historical data in the analysis of clinical ... · Joost van Rosmalen1, David Dejardin2;3, and Emmanuel Lesa re1;2 1Department of Biostatistics, Erasmus MC, Rotterdam, the

Modified power priors: theoretical overview and sampling algorithms

Introduction

0.3 0.4 0.5 0.6 0.7

05

1015

p (probability of success)

Pos

terio

r de

nsity

of p

New study onlyPooled data

Current data: k= 50 n= 100 , historical data: k= 50 n= 100

Bayes Pharma meeting 2014 5 / 25

Page 6: Including historical data in the analysis of clinical ... · Joost van Rosmalen1, David Dejardin2;3, and Emmanuel Lesa re1;2 1Department of Biostatistics, Erasmus MC, Rotterdam, the

Modified power priors: theoretical overview and sampling algorithms

Introduction

Alternative to pooling: include historical data in the analysis, butassign lower weight to historical data.

Ibrahim & Chen (Stat. Science, 2000) proposed power prior:

πCPP(β|H, θ) ∝ LH(β)θp(β),

with p(β) the prior density of model parameters, H the historicaldata, and θ (with 0 ≤ θ ≤ 1) the relative weight of the historical data.

Referred to as conditional power prior (CPP)

Combining with likelihood of new data set D yields posterior:

pCPP(β|D,H, θ) ∝ LD(β)LH(β)θp(β).

Bayes Pharma meeting 2014 6 / 25

Page 7: Including historical data in the analysis of clinical ... · Joost van Rosmalen1, David Dejardin2;3, and Emmanuel Lesa re1;2 1Department of Biostatistics, Erasmus MC, Rotterdam, the

Modified power priors: theoretical overview and sampling algorithms

Theoretical overview

Chen & Ibrahim (Bayesian Analysis, 2006): specific choices of θ inCPP equivalent to meta-analysis.

Gaussian model for current (yD1 , . . . yDnD

) and hist. data (yH1 , . . . yHnH

)

yD1 , . . . yDn ∼ N(µD , σ

2D) and yH1 , . . . y

HnH∼ N(µH , σ

2H)

µD ∼ N(µ, τ2) and µH ∼ N(µ, τ2)

p(µ) ∝ 1

Result: distribution of µH given yD1 , . . . yDn and yH1 , . . . y

HnH

equal toCPP with:

θ =1

2τ2nH/σ2H + 1

Results can be extended to linear regression, GLMs.

Bayes Pharma meeting 2014 7 / 25

Page 8: Including historical data in the analysis of clinical ... · Joost van Rosmalen1, David Dejardin2;3, and Emmanuel Lesa re1;2 1Department of Biostatistics, Erasmus MC, Rotterdam, the

Modified power priors: theoretical overview and sampling algorithms

Theoretical overview

Alternative approach: estimate θ using observed data.

Result: adaptive pooling of historical and current data.

Original power prior (Ibrahim & Chen, 2000):

πOPP(β, θ|D,H) ∝ LH(β)θp(β)p(θ),

with p(θ) prior distribution of weight parameter.

Bayes Pharma meeting 2014 8 / 25

Page 9: Including historical data in the analysis of clinical ... · Joost van Rosmalen1, David Dejardin2;3, and Emmanuel Lesa re1;2 1Department of Biostatistics, Erasmus MC, Rotterdam, the

Modified power priors: theoretical overview and sampling algorithms

Theoretical overview

Duan et al. (Environmetrics, 2006): πOPP(β, θ|D,H) does not satisfylikelihood principle.

Multiplying LH(β) by arbitrary constant k yields

πOPP(β, θ|D,H) ∝ kθLH(β)θp(β)p(θ),

thus changing posterior distribution of θ.

Original power prior gives low values of θ in large data sets, even ifLD(β) = LH(β).

Bayes Pharma meeting 2014 9 / 25

Page 10: Including historical data in the analysis of clinical ... · Joost van Rosmalen1, David Dejardin2;3, and Emmanuel Lesa re1;2 1Department of Biostatistics, Erasmus MC, Rotterdam, the

Modified power priors: theoretical overview and sampling algorithms

Theoretical overview

Duan et al. (2006) proposed modified power prior (MPP):

πMPP(β, θ|H) ∝ C (θ)LH(β)θp(β)p(θ),

with

C (θ) =1∫

LH(β)θp(β)dβ.

Bayes Pharma meeting 2014 10 / 25

Page 11: Including historical data in the analysis of clinical ... · Joost van Rosmalen1, David Dejardin2;3, and Emmanuel Lesa re1;2 1Department of Biostatistics, Erasmus MC, Rotterdam, the

Modified power priors: theoretical overview and sampling algorithms

Theoretical overview

0.0 0.2 0.4 0.6 0.8 1.0

02

46

810

θ (weight of historical data)

Pos

terio

r de

nsity

of θ

Modified power priorOriginal power prior

Bayes Pharma meeting 2014 11 / 25

Page 12: Including historical data in the analysis of clinical ... · Joost van Rosmalen1, David Dejardin2;3, and Emmanuel Lesa re1;2 1Department of Biostatistics, Erasmus MC, Rotterdam, the

Modified power priors: theoretical overview and sampling algorithms

Theoretical overview

0.3 0.4 0.5 0.6 0.7

05

1015

p (probability of success)

Pos

terio

r de

nsity

of p

New study onlyPooled dataModified power prior

Current data: k= 50 n= 100 , historical data: k= 50 n= 100

Bayes Pharma meeting 2014 12 / 25

Page 13: Including historical data in the analysis of clinical ... · Joost van Rosmalen1, David Dejardin2;3, and Emmanuel Lesa re1;2 1Department of Biostatistics, Erasmus MC, Rotterdam, the

Modified power priors: theoretical overview and sampling algorithms

Sampling algorithms

Using MPP, prior involves integral∫LH(β)θp(β) dβ in C (θ).

In MCMC sampler, C (θ) must be available in every iteration:large computation time not acceptable.

Possible approaches for simple models:

Analytical integrationNumerical integration

MPP has only been applied in models with closed-form posterior.

New algorithms for complex models:

Laplace approximation (talk of David)Path sampling

Bayes Pharma meeting 2014 13 / 25

Page 14: Including historical data in the analysis of clinical ... · Joost van Rosmalen1, David Dejardin2;3, and Emmanuel Lesa re1;2 1Department of Biostatistics, Erasmus MC, Rotterdam, the

Modified power priors: theoretical overview and sampling algorithms

Sampling algorithms: path sampling

Friel and Pettitt (JRSS-B, 2008): calculation of marginal likelihoodusing power posteriors.

Weight parameter used as auxiliary variable for calculating marginallikelihood (i.e.

∫LH(β)θp(β) dβ with θ = 1).

Idea of algorithm: logarithm of C (θ) equals integrated log-likelihood:

log

(∫LH(β)θp(β)dθ

)=

∫ θ

θ∗=0ELH(β)θ∗p(β) [log(LH(β))] dθ∗,

with β distributed as LH(β)θ∗p(β).

Bayes Pharma meeting 2014 14 / 25

Page 15: Including historical data in the analysis of clinical ... · Joost van Rosmalen1, David Dejardin2;3, and Emmanuel Lesa re1;2 1Department of Biostatistics, Erasmus MC, Rotterdam, the

Modified power priors: theoretical overview and sampling algorithms

Sampling algorithms: path sampling

Path sampling algorithm:

Choose ∆θ (step size for θ) and niter (iterations per step). Set θ = 0.

Repeat until θ = 1:1 Increase θ by ∆θ.2 Sample niter MCMC iterations from LH(β)θp(β).3 Calculate log(LH(β)) as the average of log(LH(β)) using βs sampled

for the current value of θ

Calculate cumulative sum of log(LH(β)), as a function of θ.∫LH(β)θp(β) dβ is proportional to exponential of the cumulative sum.

Bayes Pharma meeting 2014 15 / 25

Page 16: Including historical data in the analysis of clinical ... · Joost van Rosmalen1, David Dejardin2;3, and Emmanuel Lesa re1;2 1Department of Biostatistics, Erasmus MC, Rotterdam, the

Modified power priors: theoretical overview and sampling algorithms

C (θ) calculated for finite number of points in [0, 1]

For intermediate values: use linear interpolation of log(C (θ))

Few or no burn-in iterations required per value of θ.

Numerical comparisons show that path sampling algorithm isaccurate.

For posterior results of MPP: use MCMC sampler and look up valueof C (θ) in every iteration.

Bayes Pharma meeting 2014 16 / 25

Page 17: Including historical data in the analysis of clinical ... · Joost van Rosmalen1, David Dejardin2;3, and Emmanuel Lesa re1;2 1Department of Biostatistics, Erasmus MC, Rotterdam, the

Modified power priors: theoretical overview and sampling algorithms

Behaviour of modified power prior

If LH(β) = LD(β) and p(θ) = 1, posterior mode of θ is 1.

But posterior CI of θ often very wide.

Illustration with Gaussian model using results of Duan et al. (2006).

Bayes Pharma meeting 2014 17 / 25

Page 18: Including historical data in the analysis of clinical ... · Joost van Rosmalen1, David Dejardin2;3, and Emmanuel Lesa re1;2 1Department of Biostatistics, Erasmus MC, Rotterdam, the

Modified power priors: theoretical overview and sampling algorithms

Behaviour of modified power prior

Gaussian model: historical and current data N(µ, σ2)

Beta(1,1) prior (i.e. uniform) for θ

Jeffreys prior for µ and σ2, π(µ, σ2) = (1/σ2)3/2

n = 100, x̄ = 0, s2 = 1 for current data

Three settings for historical data:1 n0 = 100, x̄H = 0, s2

0 = 12 n0 = 100, x̄H = 0.5, s2

0 = 13 n0 = 100, x̄H ∈ [−4, 4], s2

0 = 1

Bayes Pharma meeting 2014 18 / 25

Page 19: Including historical data in the analysis of clinical ... · Joost van Rosmalen1, David Dejardin2;3, and Emmanuel Lesa re1;2 1Department of Biostatistics, Erasmus MC, Rotterdam, the

Modified power priors: theoretical overview and sampling algorithms

Behaviour of modified power prior

Figure: Posterior distribution of θ with equal historical and current data

0.0 0.2 0.4 0.6 0.8 1.0

0.0

0.5

1.0

1.5

2.0

θ (weight of historical data)

Pos

terio

r de

nsity

of θ

Bayes Pharma meeting 2014 19 / 25

Page 20: Including historical data in the analysis of clinical ... · Joost van Rosmalen1, David Dejardin2;3, and Emmanuel Lesa re1;2 1Department of Biostatistics, Erasmus MC, Rotterdam, the

Modified power priors: theoretical overview and sampling algorithms

Behaviour of modified power prior

Figure: Posterior distribution of θ with x̄ = 0 and x̄H = 0.5

0.0 0.2 0.4 0.6 0.8 1.0

0.0

0.5

1.0

1.5

2.0

2.5

3.0

θ (weight of historical data)

Pos

terio

r de

nsity

of θ

Bayes Pharma meeting 2014 20 / 25

Page 21: Including historical data in the analysis of clinical ... · Joost van Rosmalen1, David Dejardin2;3, and Emmanuel Lesa re1;2 1Department of Biostatistics, Erasmus MC, Rotterdam, the

Modified power priors: theoretical overview and sampling algorithms

Behaviour of modified power prior

Figure: Posterior mean of θ as a function of x̄H

−4 −2 0 2 4

0.0

0.2

0.4

0.6

0.8

1.0

Sample average of historical data

Pos

terio

r m

ean

of θ

(w

eigh

t of h

isto

rical

dat

a)

Bayes Pharma meeting 2014 21 / 25

Page 22: Including historical data in the analysis of clinical ... · Joost van Rosmalen1, David Dejardin2;3, and Emmanuel Lesa re1;2 1Department of Biostatistics, Erasmus MC, Rotterdam, the

Modified power priors: theoretical overview and sampling algorithms

Behaviour of modified power prior

Figure: Posterior mean of µ as a function of x̄H

−4 −2 0 2 4

−0.

2−

0.1

0.0

0.1

0.2

Sample average of historical data

Pos

terio

r m

ean

of µ

Bayes Pharma meeting 2014 22 / 25

Page 23: Including historical data in the analysis of clinical ... · Joost van Rosmalen1, David Dejardin2;3, and Emmanuel Lesa re1;2 1Department of Biostatistics, Erasmus MC, Rotterdam, the

Modified power priors: theoretical overview and sampling algorithms

Behaviour of modified power prior

Largest effect of historical data when x̄ = 0 and x̄H ≈ 0.41,corresponding with significant difference in frequentist analysis(p-value two-sample t-test: 0.005).

In Gaussian model, posterior mean of θ never becomes 1 using flatprior for θ.

Scaling constant∫βLH(β)θp(β) dβ is not finite with reference prior

f (µ, σ2) = 1σ2 (Duan et al. 2006)

Bayes Pharma meeting 2014 23 / 25

Page 24: Including historical data in the analysis of clinical ... · Joost van Rosmalen1, David Dejardin2;3, and Emmanuel Lesa re1;2 1Department of Biostatistics, Erasmus MC, Rotterdam, the

Modified power priors: theoretical overview and sampling algorithms

Discussion

Modified power prior is an interesting and versatile method.

Advantages:

Applicable to any parametric Bayesian modelNormality assumption for parameters not needed.Adaptive pooling happens automatically.

Limitations:

Any discrepancy between historical and current data leads todownweighting.Amount of discounting often considered too severe (Neelon &O’Malley, J Biomet Biostat 2010).Unclear how prior of θ must be chosen.Implementation requires more work than standard Bayesian analysis.

Bayes Pharma meeting 2014 24 / 25

Page 25: Including historical data in the analysis of clinical ... · Joost van Rosmalen1, David Dejardin2;3, and Emmanuel Lesa re1;2 1Department of Biostatistics, Erasmus MC, Rotterdam, the

Modified power priors: theoretical overview and sampling algorithms

Discussion

Topics for future research:

Definition of modified power prior with multiple historical data sets.Comparison of MPP with other methods, e.g. meta-analysis.What to do if

∫βLH(β)θp(β)dβ is not finite for all θ ∈ (0, 1)

Frequentist characteristics

Theoretical understanding of MPP needs to be improved.

Bayes Pharma meeting 2014 25 / 25